Body Composition Outcomes in MS Patients
NCT07530718
Summary
Objectives The objective of this project is to generate pilot data substantiating our hypothesis that advanced body composition measurement tools will provide more accurate and clinically relevant data on the outcomes of metabolic surgery (MS) in patients with severe obesity compared to traditional methods. To achieve this objective, the investigators propose the following aims: Aim 1: Evaluate the effectiveness of different body composition measurement tools in assessing outcomes in patients with severe obesity undergoing MS. Aim 2: Assess the changes in body composition and muscle strength following MS. Aim 3: Compare body compositions changes between SG and RYGB patients.
Eligibility
Inclusion Criteria: * Being either male or female * Being an adult greater or equal to 18 years of age * BMI ≥40 kg/m2 * Weigh less than 440 pounds * Being willing to comply with the study procedures * Being scheduled for primary metabolic surgery (either Sleeve Gastrectomy or Roux-en-Y Gastric bypass) Exclusion Criteria: * Previous bariatric surgery or other complex abdominal surgery * Poorly controlled medical or psychiatric disorders * For women in child-bearing ages, being pregnant or attempting to become pregnant or currently breastfeeding * Having metal-containing objects in their body that may cause artifact on MRI * Having medical implants such as a pacemaker or metal joint replacements * Having a body weight greater than 440 pounds * Comorbid conditions that may affect body composition measurements, such as advanced liver disease or severe cardiovascular disease. * Cannot understand risks, benefits, and compliance required to participate.
Conditions2
Locations2 sites
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07530718